CD24hiCD27+ B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide

Clinical and Experimental Allergy

Volumn 44, Issue 4, 2014, Pages 517-528

  Van der Vlugt, L E P M ^a   Mlejnek, E ^a   Ozir Fazalalikhan, A ^a   Janssen Bonas, M ^a   Dijksman, T R ^a   Labuda, L A ^a   Schot, R ^a   Guigas, B ^a   Moller G M ^a   Hiemstra, P S ^a   Yazdanbakhsh, M ^a   Smits, H H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allergy; Asthma; Human; IL 10; Regulatory B cells

Indexed keywords

ALLERGEN; B LYMPHOCYTE RECEPTOR; DERP1; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; CD24 ANTIGEN; CD27 ANTIGEN; TOLL LIKE RECEPTOR 4;

ADULT; ALLERGIC ASTHMA; ARTICLE; B LYMPHOCYTE; BLOOD; CD24 HI CD27 + B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; YOUNG ADULT; ASTHMA; CASE CONTROL STUDY; IMMUNOLOGY; IMMUNOPHENOTYPING; LUNG FUNCTION TEST; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD24; ANTIGENS, CD27; ASTHMA; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84897848280     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12238     Document Type: Article

References (46)

1. Strachan D, Sibbald B, Weiland S et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997; 8:161-76.
2. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1:69-75.
3. Ege MJ, Mayer M, Schwaiger K et al. Environmental bacteria and childhood asthma. Allergy 2012; 67:1565-71.
4. Ege MJ, Mayer M, Normand AC et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364:701-9.
5. Karvonen AM, Hyvarinen A, Gehring U et al. Exposure to microbial agents in house dust and wheezing, atopic dermatitis and atopic sensitization in early childhood: a birth cohort study in rural areas. Clin Exp Allergy 2012; 42:1246-56.
6. von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 2010; 10:861-8.
7. Robinson DS, Regulatory T. Cells and asthma. Clin Exp Allergy 2009; 39:1314-23.
8. Vitale G, Mion F, Pucillo C. Regulatory B cells: evidence, developmental origin and population diversity. Mol Immunol 2010; 48:1-8.
9. Dilillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010; 1183:38-57.
10. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012; 30:221-41.
11. Smits HH. B cells in allergic diseases: bad or better? Autoimmunity 2012; 45:415-26.
12. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010; 125:1114-24.
13. Smits HH, Hammad H, van Nimwegen M et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection. J Allergy Clin Immunol 2007; 120:932-40.
14. van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A et al. Schistosomes induce regulatory features in human and mouse CD1dhi B cells: inhibition of inflammation by IL-10 and enhanced regulatory T cells. PLoS ONE 2012; 7:e30883.
15. Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, Smits HH. Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011; 128:733-9.
16. Blair PA, Norena LY, Flores-Borja F et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32:129-40.
17. Iwata Y, Matsushita T, Horikawa M et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117:530-41.
18. Das A, Ellis G, Pallant C et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012; 189:3925-35.
19. Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008; 64:187-99.
20. Duddy M, Niino M, Adatia F et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007; 178:6092-9.
21. Palanivel V, Posey C, Horauf AM, Solbach W, Piessens WF, Harn DA. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 1996; 84:168-77.
22. Sayi A, Kohler E, Toller IM et al. TLR-2-activated B cells suppress helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 2011; 186:878-90.
23. Neves P, Lampropoulou V, Calderon-Gomez E et al. Signalling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010; 33:777-90.
24. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14:32-8.
25. Milovanovic M, Heine G, Zuberbier T, Worm M. Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. Clin Exp Allergy 2009; 39:671-8.
26. Benkhart EM, Siedlar M, Wedel A, Werner T, Ziegler-Heitbrock HW. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol 2000; 165:1612-17.
27. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10:170-81.
28. Jin G, Hamaguchi Y, Matsushita T et al. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 2013; 131:1674-82.
29. Braun-Fahrlander C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
30. van Strien RT, Engel R, Holst O et al. Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health. J Allergy Clin Immunol 2004; 113:860-7.
31. Gehring U, Strikwold M, Schram-Bijkerk D et al. Asthma and allergic symptoms in relation to house dust endotoxin: Phase Two of the International Study on Asthma and Allergies in Childhood (ISAAC II). Clin Exp Allergy 2008; 38:1911-20.
32. Gereda JE, Leung DY, Thatayatikom A et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000; 355:1680-3.
33. Sordillo JE, Hoffman EB, Celedon JC, Litonjua AA, Milton DK, Gold DR. Multiple microbial exposures in the home may protect against asthma or allergy in childhood. Clin Exp Allergy 2010; 40:902-10.
34. Lappalainen MH, Hyvarinen A, Hirvonen MR et al. High indoor microbial levels are associated with reduced Th1 cytokine secretion capacity in infancy. Int Arch Allergy Immunol 2012; 159:194-203.
35. Roy SR, Schiltz AM, Marotta A, Shen Y, Liu AH. Bacterial DNA in house and farm barn dust. J Allergy Clin Immunol 2003; 112:571-8.
36. Lauener RP, Birchler T, Adamski J et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002; 360:465-6.
37. Ege MJ, Bieli C, Frei R et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006; 117:817-23.
38. Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:4531-7.
39. Jagannathan M, Hasturk H, Liang Y et al. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 2009; 183:7461-70.
40. Shin H, Zhang Y, Jagannathan M et al. B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol 2009; 85:648-55.
41. McDonnell M, Liang Y, Noronha A et al. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:298-307.
42. Ganley-Leal LM, Liang Y, Jagannathan-Bogdan M, Farraye FA, Nikolajczyk BS. Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol 2010; 48:82-8.
43. Tsai JJ, Liu SH, Yin SC et al. Mite allergen Der-p2 triggers human B lymphocyte activation and Toll-like receptor-4 induction. PLoS ONE 2011; 6:e23249.
44. Prefontaine D, Banville-Langelier AA, Fiset PO et al. Children with atopic histories exhibit impaired lipopolysaccharide-induced Toll-like receptor-4 signalling in peripheral monocytes. Clin Exp Allergy 2010; 40:1648-57.
45. Noh J, Lee JH, Noh G et al. Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br 1) in Cow Milk Allergy. Cell Immunol 2010; 264:143-9.
46. Akkoc T, Akdis M, Akdis CA. Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res 2011; 3:11-20.